|
Volumn 17, Issue 6, 2002, Pages 1610-1615
|
Are fertility drugs a risk factor for persistent trophoblastic tumour?
|
Author keywords
Hydatidiform mole; Metastasis; Ovulation induction; Persistent trophoblastic tumour
|
Indexed keywords
CLOMIFENE;
FERTILITY PROMOTING AGENT;
GONADOTROPIN;
ADULT;
ARTICLE;
CANCER RISK;
CHILDBIRTH;
CLINICAL OBSERVATION;
CONTROLLED STUDY;
DELIVERY;
DRUG EXPOSURE;
FEMALE;
FEMALE INFERTILITY;
GESTATION PERIOD;
HUMAN;
HYDATIDIFORM MOLE;
INFERTILITY THERAPY;
MAJOR CLINICAL STUDY;
MEDICAL LITERATURE;
MEDLINE;
METASTASIS;
MULTIPLE PREGNANCY;
OVULATION INDUCTION;
PREGNANCY;
RISK FACTOR;
TROPHOBLASTIC TUMOR;
VAGINA BLEEDING;
NEWBORN;
PREGNANCY OUTCOME;
UTERUS CANCER;
ADULT;
FEMALE;
HUMANS;
HYDATIDIFORM MOLE;
INFANT, NEWBORN;
OVULATION INDUCTION;
PREGNANCY;
PREGNANCY OUTCOME;
PREGNANCY, MULTIPLE;
RISK FACTORS;
TROPHOBLASTIC NEOPLASMS;
UTERINE NEOPLASMS;
|
EID: 0035989390
PISSN: 02681161
EISSN: None
Source Type: Journal
DOI: 10.1093/humrep/17.6.1610 Document Type: Article |
Times cited : (16)
|
References (23)
|